Skip to content

Safety and efficacy of Naga Bhasma in diabetes mellitus

Comparative pharmaceutico pharmacological profile of Trinshati and Shashti Puta Naga Bhasma and their efficacy in the management of Madhumeha (Type II DM)

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007765
Enrollment
90
Registered
2017-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Madhumeha (Diabetes mellitus type 2)

Interventions

Intervention1: Naga Bhasma: In one group, patients will be treated with 30 Puta Naga Bhasma (125 mg) and Nisha(125 mg) with Amalaki Churna(125 mg) once daily in capsule form early morning in empty sto

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical symptomatology (Prabhuta Mutrata, Avila Mutrata, Kshudhadhikya, Trishnadhikya, Kara-Pada-tala Daha, Kara-Pada Suptata etc.) of Madhumeha Symptoms of Diabetes (Polyuria, Polydipsia, Polyphagia and Weight loss.) Both the sexes having Age between 30 years to 60 years. Patients having Blood sugar Fasting more than 126 and equal to or less than 200 mg/dl or PPBS more than 200 mg/dl

Exclusion criteria

Exclusion criteria: Age below 30 and above 60 years. Patients of Diabetes Mellitus receiving Insulin. Malignant and accelerated Hypertension. Patients having chronic complications of Diabetes Mellitus

Design outcomes

Primary

MeasureTime frame
It is expected that the trial drugs will exert a significant action over FBS and PPBS and other associated symptomsTimepoint: 18 months

Secondary

MeasureTime frame
By maintaining the healthy level of blood sugar, the drug will control conditions associated with diabetes like various cardiovascular diseases, obesity and improve quality of lifeetc.Timepoint: 60 days

Countries

India

Contacts

Public ContactBJ Patgiri

Institute for Pst Graduate Teaching and Research in Ayurveda

patgiri124@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026